Avandia “can make some heart problems worse or lead to heart failure” says Glaxo

The irony of it all – in support of Avandia, Glaxo has been forced to take out full page ads in publications such as The New York Times, The Washington Post, USA Today and The Wall Street Journal. These ads which are intended to reassure patients of the safety of the widely used medicine take the form of a letter to Avandia patients signed by Ronald Krall, chief medical officer of the world’s second- largest drugmaker.

The four paragraph letter concludes, “Be assured, GSK gives you our full commitment to providing you and your doctor with the facts about the safety of Avandia.”

However, about a quarter of the newspaper page is taken up by obligatory safety warnings in the same prominent typeface used for the letter. It includes a caution that Avandia can cause fluid retention, which “can make some heart problems worse or lead to heart failure.”

Read the full article by Bill Berkrot here at Scientific American.

4 Responses to “Avandia “can make some heart problems worse or lead to heart failure” says Glaxo”

  1. truthman30 Says:

    A bit like Seroxat then?…

    Seroxat causes depression, anxiety and panic…( which it’s supposed to treat)

    Myodil causes damage of the spine (although they used it in xrays which were supposed to help those with back problems)

    And now we have Avandia , a medication which is supposed to treat diabetics ( who have a higher rate of heart attacks) …

    But Avandia has been found to be causing heart problems…

    You gotta hand it to GSK…

    They sure do know how to make some of the worst drugs on the market….

    http://truthman30.wordpress.com/2007/02/02/gsk-have-quite-the-history-of-dodgy-drugs/

    I wonder has anyone done a survey on the exact figure of how many people GSK have killed, harmed or maimed with their crap drugs over the years?…

    I’m sure it could be well into the tens of thousands….

  2. Matthew Holford Says:

    Well, a while back, I did a thumbnail calculation, based upon a 0.65% increased risk of suicidality, when taking Seroxat (i.e, 0.77%, as against 0.12% on placebo – I forget where those figures came from). Based on 50mm Seroxat patients, worldwide, we have an extra 325,000 people at risk of suicidality. How many of those go on to “complete”, is a matter for conjecture.

    Matt

  3. Matthew Holford Says:

    Actually, I think I do remember. I think it was Aursnes’ study.

    Matt

  4. truthman30 Says:

    ahh so it’s well into the hundreds of thousands…


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: